In Vivo Evaluation Using Gamma Scintigraphy - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

In Vivo Evaluation Using Gamma Scintigraphy
The authors discuss gamma scintigraphy as a technique for in vivo evaluation of drugs and delivery systems.


Pharmaceutical Technology


References

1. S. Jain, P. Dani, and R.K. Sharma, Crit. Rev. Ther. Drug 26 (4), 373–426 (2009).

2. S.P. Newman, P.H. Hirst, and I.R. Wilding, Eur. J. Pharm. Sci. 18 (1), 19–22 (2003).

3. Y.S.R. Krishnaina, S. Satyanarayana, and Y.V. Rama Prasad, J. Pharm. Sci. 5 (1), 24–28 (2002).

4. C.G. Wilson and N. Washington, "Gamma Scinitigraphy in the Analysis of the Behavior of Controlled Release Systems," in Handbook of Pharmaceutical Controlled Release Technology (Marcel Dekker, New York, 1st ed., 2005), pp. 551–565.

5. N.K. Jain, "Colon-Specific Drug Delivery Systems," in Advances in Controlled and Novel Drug Delivery (CBS Publishers, New Delhi, India, 1st ed., 2006), pp. 104–109.

6. I.R. Wilding, A.J. Coupe, and S.S. Davis, Adv. Drug. Deliver. Rev. 46 (1), 103–124 (2001).

7. "H.F. Solomn, H.D. Burns, and R.E. Gibson, Drug. Dev. Ind. Pharm. 16 (18), 2655–2673 (1990).

8. G. Meseguer, R. Gurny, and P. Buri, J. Drug Target. 2 (4), 269–288 (1994).

9. A.W. Basit et al., Eur. J. Pharm. Sci. 21 (2–23), 179–189 (2004).

10. "Methods of Radiolabeling," Quotient Bioresearch (Cambridgeshire, UK), http://www.quotientbioresearch.com/methods-radiolabeling/, accessed Oct. 18, 2010.

12. G.A. Digenis, E.P. Sandefer, R.C. Page, and W.J. Doll, Pharm. Sci. Technol. Today, 1 (3), 100–107 (1998).

13. L. Yang, J.S. Chu, and J.A. Fix, "Int. J. Pharm. 235 (1–2), 1–15 (2002).

14. S. Connolly, CRS Newlsetter 25 (4), 16–17 (2008).

15. M.S. Berridges, D.L. Heald, and Z. Lee, Drug. Dev. Res. 59 (2), 208–209 (2003).

16. K. Jones, "New Technology Combo Drives Once-Daily Drug Formulation," http://www.iptonline.com/articles/public/IPT_26_p66nonprint.pdf, accessed Sept. 27, 2010.

17. A.K. Singh, N. Bhardwaj, and A. Bhatnagar, Indian J. Pharm. Sci. 66 (1), 18–25 (2004).

18. "Pharmacoscintigraphy," Quotient Bioresearch (Cambridgeshire, UK), http://www.quotientbioresearch.com/pharmacoscintigraphy, accessed Oct. 18, 2010.

19. P.P. Hazari, et al., Bioconjugate. Chem. 21 (2), 229–239 (2010).

20. A. Pathak et al., ACS. Nano. 3 (6), 1493–1505 (2009).

21. D. Wang et al., Mol. Pharm. 3 (6), 717–725 (2006).

22. IAEA, "Radiation Protection Procedures," in International Atomic Energy Agency Safety Series (New York, 1978).


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
20%
To all process for new products only
13%
To select process for new products only
25%
To select processes for both new and legacy products
20%
Do not use QbD
23%
View Results
UPCOMING CONFERENCES

Programs for Investigational and Pre-Launch Drugs
Philadelphia, PA
July 17-18, 2013
Request Brochure

Strategic Pipeline Planning & Portfolio Valuation
Philadelphia, PA
August 13-14, 2013
Request Brochure

MES 2013 - Forum on Manufacturing Execution Systems
Philadelphia, PA
August 14-15, 2013
Request Brochure

Mobile Innovation for the Life Sciences Industry
Philadelphia, PA
August 20-21, 2013
Request Brochure

See All Conferences >>

Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
Global Biosimilars Market to Reach $2.445 Billion in 2013
Adapting to Change
AstraZeneca and Exco InTouch Collaborate to Augment Current COPD Pathways
Overcoming the Challenges in Biopharmaceutical Stability Testing
PhRMA Dismayed by Special 301 Report
FindPharma Custom Search
Source: Pharmaceutical Technology,
Click here